[4] Other Applicants Under Review Several additional generic manufacturers have submissions under Health Canada review, including Sandoz, Teva Canada, Taro Pharmaceuticals, Aspen Pharmacare, and Vimy Pharma (an Edmonton-based company co-founded by former Novo Nordisk Canada executives)
*Pricing Note: $250 a month includes all fees for 2 months or more prepaid
Safety must remain a top priority during peptide preparation or hormone administration
In my experience, patients taking injectable semaglutide typically lose more weight than those on oral semaglutide, says Craig Primack, MD , a physician specializing in obesity medicine and senior vice president of weight management at Hims & Hers
Start Now References European Medicines Agency, 2025
Fears about safety data which doesnt currently exist for 10+ years of use develop